Study of Durvalumab + Tremelimumab in NSCLC Patients After Adjuvant Treatment

Name: Study of Durvalumab + Tremelimumab in NSCLC Patients After Adjuvant Treatment
License: Public Domain

Catherine Shu

ClinicalTrials.gov · Datasets · License: Public Domain

nonsmall cell lung cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 160343
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.